Business

LeMaitre to Participate at Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three

articleLemaitre Vascular, Inc.November 2, 20215/company/lemaitre-vascular-inc/news/lemaitre-to-participate-at-upcoming-investor-conferences-2021-11-02
LeMaitre to Participate at Upcoming Investor Conferences

About this update from Lemaitre Vascular, Inc.

[{"type":"text","content":"BURLINGTON, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming virtual investor conferences. Stifel 2021 Virtual Healthcare ConferenceMonday, November 15, 2021David Roberts, President, will present at 8:40 AM ET Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services ForumThursday, November 18, 2021JJ Pellegrino, Chief Financial Officer, is scheduled to host a series of 1x1 meetings Piper Sandler 33rd Virtual Annual Healthcare ConferenceMonday, November 29 – Thursday, December 2, 2021A pre-recorded presentation by David Roberts, President, will be available About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com. Contact:\nLeMaitre Vascular, Inc.\nSandra Millar\n+1-781-425-1686\[email protected]\nSource: LeMaitre Vascular, Inc.","length":2841,"tagName":"div"}]

More updates from Lemaitre Vascular, Inc.